Startup raises $4M to 3-D print drug delivery wafers; Aradigm's liposomes protect mice from the plague;

> Aprecia Pharmaceuticals has raised $4 million to develop and advance its 3-D printer technology to create taste-masked, fast-melt drug delivery wafers that disperse in the mouth in just 5 seconds. Article

> Algeta and Ablynx are evaluating a targeted thorium conjugate, which will combine Algeta`s thorium-227 alpha-pharmaceutical payload with Nanobodies generated using Ablynx`s technology platform. Press release

> Aradigm's liposomal ciprofloxacin protected mice from the plague. Press release

> Advanced Cardiovascular Systems has patented its molded coronary stent that carries reservoirs of drugs. Article

> Homing beacon drugs could target cancer cells--and all presented by a researcher in a "Movember" 'tache! Press release | Article

And Finally… Nanowiffle balls could carry cancer drugs. Article

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.